Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Market Analysis
High healthcare costs boost increased focus on biosimilar markets, market study shows
January 29th, 2007
The drive for increased cost savings by healthcare providers is increasing the focus on boosting the biosimilar market, according to a new report released by Research and Markets, "Biosimilars: Regulatory Issues - Europe Continues to make Strides while the U.S. Lags Behind." With a regulatory approval pathway in place in Europe and substantial guidelines to support biosimilar development, the European biosimilars market is significantly more advanced than the U.S., where plans for a biosimilar regulatory approval pathway have stalled. Although the U.S. Food and Drug Administration (FDA) was relatively pro-biosimilars from 1999-2004, the release of...
Source: Biotech Business Week (2007-01-29)
|
